242 related articles for article (PubMed ID: 33052714)
1. Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension.
Yerabolu D; Weiss A; Kojonazarov B; Boehm M; Schlueter BC; Ruppert C; Günther A; Jonigk D; Grimminger F; Ghofrani HA; Seeger W; Weissmann N; Schermuly RT
Am J Respir Cell Mol Biol; 2021 Jan; 64(1):100-114. PubMed ID: 33052714
[TBL] [Abstract][Full Text] [Related]
2. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
3. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
4. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.
Roger I; Milara J; Montero P; Cortijo J
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067108
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid ameliorates pulmonary hypertension via inhibition of tyrosine kinase Fyn.
Kurahara LH; Hiraishi K; Yamamura A; Zhang Y; Abe K; Yahiro E; Aoki M; Koga K; Yokomise H; Go T; Ishikawa K; Bo Z; Kishi H; Kobayashi S; Aoki-Shoi N; Toru S; Inoue R; Hirano K
J Mol Cell Cardiol; 2020 Nov; 148():50-62. PubMed ID: 32889002
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor up-regulates Ca
Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
[TBL] [Abstract][Full Text] [Related]
11. miR-223 reverses experimental pulmonary arterial hypertension.
Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
[TBL] [Abstract][Full Text] [Related]
12. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
[TBL] [Abstract][Full Text] [Related]
14. Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Lemay SE; Grobs Y; Romanet C; Martineau S; Salem M; Shimauchi T; Breuils-Bonnet S; Bourgeois A; Théberge C; Pelletier A; Potus F; Provencher S; Bonnet S; Boucherat O
Am J Respir Crit Care Med; 2024 Jun; 209(11):1376-1391. PubMed ID: 38261723
[No Abstract] [Full Text] [Related]
15. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
16. Berberine alleviates pulmonary hypertension through Trx1 and β-catenin signaling pathways in pulmonary artery smooth muscle cells.
Wande Y; Jie L; Aikai Z; Yaguo Z; Linlin Z; Yue G; Hang Z
Exp Cell Res; 2020 May; 390(1):111910. PubMed ID: 32147507
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
19. The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension.
Schlueter BC; Quanz K; Baldauf J; Petrovic A; Ruppert C; Guenther A; Gall H; Tello K; Grimminger F; Ghofrani HA; Weissmann N; Seeger W; Schermuly RT; Weiss A
Vascul Pharmacol; 2024 Jun; 155():107379. PubMed ID: 38762131
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
